Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020

DUBLIN, Sept. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Next Generation Sequencing (Genome/Exome sequencing/DNA sequencing) Global market - Forecast to 2020" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

Next Generation Sequencing (NGS) enables rapid sequencing of large stretches of DNA base pairs spanning entire genomes capable of producing hundreds of gigabases of data in a single sequencing run. NGS is one of the fastest growing segments in genomics, triggering several ground breaking discoveries in genomic science. NGS technologies will therefore have a striking impact on cancer management, treatments of rare diseases and future developments of genetic therapies. The global next generation sequencing market is mainly categorized into pre-sequencing, NGS platforms and services, NGS data analysis, and storage and management.

Next generation sequencing market is one of the fastest growing segments in the genomics market with an estimated CAGR of around 17.0% in the next five years. The major factors such as rapid adoption of this technology by researchers and its usability as a substitute of microarray technology in addition to its higher throughput, increased accuracy, and affordable costs are driving the next generation sequencing market growth. However, factors such as reducing capital expenditure from academic institutions and huge dependability on grants funding from the government are hampering the next generation sequencing market growth. In addition, the analysis of large amount of data generated by sequencers, and data storage and management is posing a major challenge. The growth opportunities of this market include cloud computing, rising demand for pre-sequencing, developments in NGS fully integrated instruments and rising nanopore sequencing technology.

There is a huge opportunity for this technology in the field of drug discovery, personalized medicine, agricultural and animal research.

The North American region accounts for the largest share of the next generation sequencing market. The European and Asian markets are also expected to grow due to the favorable funding from the government to adopt this technology. The major factors contributing to this market growth include rising adoption by new customers, rising adoption of high-throughput sequencing platforms by government organizations such as Biotechnology and Biological Sciences Research Council (BBSRC) (U.K.) and NHGRI (National Human Genome Research Institute) (U.S.).

The key players dominating in the next generation sequencing market include Illumina Inc. (U.S.), Life Technologies Corporation (U.S.), Roche Holding AG. (Switzerland), Pacific Biosciences of California Inc. (U.S.), Ambry Genetics Corp. (U.S.), Axeq Technologies Inc. (U.S.), Beijing Genomics Institute (China), GeneDx (U.S.), Fluidigm Corp. (U.S.), Foundation Medicine Inc. (U.S.), Good Start Genetics Inc. (U.S.), Helicos BioSciences Corp. (U.S.), Knome Inc. (U.S.), NABsys Inc. (U.S.), Oxford Nanopore Technologies Ltd. (U.K.), Pathogenica Inc. (U.S.), and QIAGEN N.V. (The Netherlands). Among these Illumina accounted for the largest market share of more than 40%. The most widely used platforms for NGS sequencing are Roche/454 Life Technologies (Pyrosequencing), the Illumina/Solexa Genome Analyzer (Sequencing by synthesis) the Applied Biosystems SOLiD System (sequencing by ligation), the Helicos, Heliscope (single molecule sequencing) and Pacific Biosciences SMRT (single molecule real time sequencing). Whole genome sequencing, targeted re-sequencing, de novo sequencing, RNA-Seq, ChIP-Seq and methyl-Seq are the major applications that use NGS data analysis tools and services.

The report provides an in depth market analysis of the above mentioned segments across the following regions:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

*This report may be ordered pre-publication and will be delivered within 30 days.*

Key Topics Covered:

1. Executive summary

2. Introduction

3. Market Analysis

4. Next Generation Sequencing market, by technology

5. Next Generation Sequencing market, by products

6. Next Generation Sequencing market, by application

7. Next Generation Sequencing market, by end users

8. Regional Market analysis

9. Company Developments

10. Major Company Profiles

Companies Mentioned:

• Agilent Technologies, Inc.
• Beijing Genome Institute
• Biomatters, Ltd.
• Genomatix Software Gmbh
• Illumina Inc.
• Life Technologies Corp.
• Pacific Biosciences of California Inc.
• QIAGEN N.V
• Roche Holding Ltd.
• Strand Life Sciences Pvt. Ltd.

For more information visit http://www.researchandmarkets.com/research/p2fpnc/next_generation

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net